Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
10
1
thursday
Siemens said the acquisition was "complementary" to its expansion into life sciences and would lift its game in a market needing more medication innovation as populations age.
© Fortune
visit website